Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

ST Robinson Humphrey Upgrades Conceptus


ST Robinson Humphrey upgrades permanent birth control manufacturer Conceptus Inc. (CPTS) to buy from neutral and sets a $9 target.

Analyst Amit Hazan says the company's peer American Medical Systems announced a plan to buy privately held Ovion Inc. Due to settlement agreement in 2003, he says Conceptus has a 30-day right of first refusal to buy Ovion and has patent litigation against Ovion.

He thinks the company could create a cash infusion from this event by negotiating with American Medical Systems to waive their option to acquire and settle litigation. Or the company could acquire Ovion, licensing technology.

Hazan also learned UnitedHealth Group is planning to reconsider its reimbursement for the Essure procedure at an upcoming meeting. He sees an 86-cent 2005 loss and trims his 51-cent 2006 loss estimate to a 44-cent loss.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus